Cephalothin

Thông số

153-61-7Số CAS

205-815-7Số EC

(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidTên IUPAC

C16H16N2O6S2Công thức hóa học

396.4 g/molKhối lượng phân tử

cephalothin; Cefalotin; 153-61-7; Cephalotin; Cefalothin; Cephalothinum; Cefalotina; Cemastin; Cefalotine; Coaxin; Averon-1; Cefalotinum; 7-(2-Thienylacetamido)cephalosporanic acid; 7-(Thiophene-2-acetamido)cephalosporin; 7-(Thiophene-2-acetamido)cephalosporanic acid; DTXSID4022783; 7-(2-(2-Thienyl)acetylamido)cephalosporanic acid; 3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid; (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; CHEBI:124991; R72LW146E6; DTXCID202783; 7-(2'-thienylacetamido)cephalosporanic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, (6R-trans)-; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate (ester); (6R,7R)-3-((acetyloxy)methyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-((2-thiophen-2-ylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; RefChem:918241; 205-815-7; (6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefalotine [INN-French]; Cefalotinum [INN-Latin]; Cefalotina [INN-Spanish]; Keflin; C16H16N2O6S2; Cephalotin acid; Cefalotin [INN]; MFCD00242614; MLS001048966; (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; NCGC00159332-02; SMR000386987; (6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefalotin (BAN); CAS-153-61-7; HSDB 3024; Cefalotina fabra (TN); EINECS 205-815-7; BRN 0945586; UNII-R72LW146E6; Cephalothin;; 6R-trans-3-((Acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-carboxylic acid; 4kox; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-, (6R,7R)-; 51098-29-4; Cephalosporin 871;; 3-(Acetoxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-(Hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid acetate; Cephalothin (Standard); Spectrum_000110; CEPHALOTHIN [MI]; Prestwick0_000719; Prestwick1_000719; Prestwick2_000719; Prestwick3_000719; Spectrum2_000121; Spectrum3_000332; Spectrum4_000269; Spectrum5_000669; CEPHALOTHIN [HSDB]; CHEMBL617; Epitope ID:116207; CEPHALOTHIN [VANDF]; CEFALOTIN [WHO-DD]; cid_6024; SCHEMBL2990; Lopac0_000283; BSPBio_000937; BSPBio_001963; KBioGR_000738; KBioSS_000550; DivK1c_000097; SPBio_000162; SPBio_002858; BPBio1_001031; GTPL8798; HY-B1275AR; orb1220906; orb1301683; CEPHALOTHIN [GREEN BOOK]; BDBM82898; HY-B1275A; KBio1_000097; KBio2_000550; KBio2_003118; KBio2_005686; KBio3_001183; NINDS_000097; HMS2267P23; MSK12016; Tox21_111579; EBC-03891; s5294; AKOS015920120; Tox21_111579_1; CCG-268605; CS-W008776; DB00456; FA32097; GS-3577; SDCCGSBI-0050271.P005; 7beta-(thiophen-2-ylacetamido)-3-acetoxymethyl-3,4-didehydrocepham-4-carboxylic acid; IDI1_000097; NCGC00023699-09; (6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid; (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; DA-51778; SBI-0050271.P004; 7-(2-thienylacetamido) cephalosporanic acid; 7-(2-thienylacetamido)-cephalosporanic acid; C2769; NS00126621; T5570; 7-(2-Thiopheneacetamido)cephalosporanic acid;; C07761; D07635; EN300-267043; F079464; SR-01000003118; Q2736126; SR-01000003118-3; BRD-K28210218-236-05-7; BRD-K28210218-236-08-1; Z1741977144; CEPHALOTHIN 7-(2-THIENYLACETAMIDO)CEPHALOSPORANIC ACID; 3-acetoxymethyl-7beta-(2-thienylacetamido) ceph-3-em-4-carboxylic acid; 3-acetoxymethyl-7beta-(2-thienylacetamido)-3-cephem-4-carboxylic acid; 3-Acetoxymethyl-7beta-(2-thienylacetamido)ceph-3-em-4-carboxylic acid; (6R,7R)-3-(acetoxymethyl)-8-keto-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(acetyloxymethyl)-8-oxidanylidene-7-(2-thiophen-2-ylethanoylamino)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[(thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidTên gọi khác